text: The<unk> (DAIS) is a double-blinded placebo-controlled study that assessed the rate of cardiovascular disease following the administration of 200 mg fenofibrate in non-insulin-dependent diabetes subjects.
option_0: Diabetes Atherosclerosis Intervention Study 
option_1: Stockholm Ischemic Heart Disease Study
option_2: Antihypertensive and lipid-lowering treatment to prevent heart attack trial
option_3: Chronic stable angina COURAGE trial
option_4: Diabetes mellitus type 2 Cost-Effectiveness of Therapy
option_5: Niacin AIM HIGH study
option_6: ASPEN Trial
option_7: Clopidogrel dosing and role of genetics: ELEVATE-TIMI 56 trial